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Antioxidant activitya b s t r a c t
Objective: The inquisitive objective of the study was to observe the antimicrobial, cytotoxicity, and
antioxidant activities of some newly synthesized metal complexes of tolfenamic acid.
Methods: While antimicrobial activity was studied by disk diffusion method, cytotoxicity was studied by
performing brine shrimp lethality bioassay. Moreover, DPPH radical scavenging potential was observed
to determine the antioxidant property of the complexes.
Results: From the disk diffusion antimicrobial screening of tolfenamic acid and its metal complexes, it
was found out that considerable antimicrobial activity in terms of zone of inhibition against the tested
organisms had been demonstrated by Cu and Zn complex of tolfenamic acid. In addition, the brine shrimp
lethality bioassay corroborated that tolfenamic acid and Cu, Co, Zn complexes of the parent NSAID exhib-
ited cytotoxicity with LC50 values 1.23 ± 0.91 lg/ml, 1.12 ± 0.12 lg/ml, 1.17 ± 0.56 lg/ml, 1.35 ± 0.24 lg/
ml respectively, compared to the vincristine sulfate had LC50 value of 0.82 ± 0.09 lg/ml. Furthermore, 1,1-
diphenyl-2-picrylhydrazyl assay revealed that in comparison with standard BHT had IC50 of 11.84 ± 0.65,
Cu and Co complex of tolfenamic acid exhibited significant antioxidant or radical-scavenging properties
with IC50 values 13.61 ± 0.58 lg/ml and 15.38 ± 0.09 lg/ml, respectively.
Conclusion: It can be postulated that metal complexes of tolfenamic acid have auspicious pharmacolog-
ical effects: antimicrobial, cytotoxicity, and antioxidant potency. Hence, these complexes might have bet-
ter therapeutic responses in future; notwithstanding, it needs further detailed analysis in other
pharmacological perspectives.
 2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are the agents
which play a vital role in the field of biological chemistry. These
drugs have shown promising effects on the treatment of painful
and inflammatory musculoskeletal disorders.1 Furthermore, in
the field of therapeutics, the metal complexes are the subjects of
extensive study.2–6 Because the metal complexes exhibit various
mechanisms of biological activities, they are the best contender
of alternate Drug delivery system. Recently, studies have shown
that metal complexes enhances the pharmacological potency whenbind with a drug molecule; eventually, some biological responses
which are far beyond the parent drug’s activities.7,8
A transition metal can exist in several oxidation states and
interact with many different negatively charged ligands to form
complexes.9 Many such complexes may have therapeutic poten-
tials. In fact, complexes of transition metals are showing promising
results in the treatment of carcinomas, lymphomas, infections,
inflammation, diabetes, and neurological disorders.10
Today, Multi-Drug Resistant (MDR) microorganisms – the so
called superbugs have become a great risk to the public health in
many parts of the world. Many studies have shown that the metal
complexes can possess strong anti-microbial activity against these
resistant microbes. Sometimes, these complexes can have stronger
activity compared to conventional drugs. Such activity may be due
to the metal ion itself, the ligand or a combination of both.11,12 In
this research, a vast range of microorganisms were used in the disk
diffusion method to investigate the anti-microbial properties of
these complexes under study. Since many metal complexes show
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antineoplastic activity in the metal complexes under study was
undertaken. Preliminary screening by the brine shrimp lethality
bioassay was performed under controlled in vitro conditions. This
test can also give an insight into the potential toxicity profile of the
compounds. Finally, antioxidant activity of these metal complexes
is also investigated. Antioxidant property is related to protecting
biological systems against the potential detrimental effects of
oxidative stress or more specifically free radicals.13 Recently, it is
receiving a lot of attention from researchers due to its relation with
DNA damage, protein modification, and enzyme activity among
others.14
There are no known research studies on these biological activi-
ties of metal complexes of tolfenamic acid; thus, the present study
was focused to investigate antimicrobial, cytotoxic, and antioxi-
dant activities of metal complexes of tolfenamic acid.
2. Material and methods
2.1. Drugs and materials
Tolfenamic acid, at highest purity, was collected from –
renowned – Eskayef Bangladesh Limited. Salts of Cu, Co, and Zn
were obtained from ACI Pharmaceuticals Ltd. Moreover, Vin-
cristine sulfate and ciprofloxacin were purchased from Square
Pharmaceuticals Ltd.
2.2. Solvents and reagents
Acetone, Tween-80, methanol, and 1,1-diphenyl-2-
picrylhydrazyl were obtained from Sigma Chemicals, USA, and also
Dimethyl sulfoxide and sodium bicarbonate were collected from
Merck, Darmstadt, Germany. Normal saline was purchased from
Opsonin Pharma Ltd; all chemicals and reagents were of analytical
grade.
2.3. Synthesis of complexes
Equimolar solutions of CuSO45H2O, CoCl26H2O, and
ZnSO47H2O in methanol (5 ml) were added to a solution of
tolfenamic acid in methanol (5 ml), separately. After that, drops
of a methanolic solution of 1 N sodium hydroxide were added to
three different solutions until the apparent pH value was ~7;
and, the mixtures were stirred for several hours at room tempera-
ture and cooled to refrigerator until the temperature dropped to
5 C. With the addition of distilled water, significant amount of
precipitation was formed, separately. The precipitates were
obtained by filtration and recrystallization; and, the powders were
washed with cold MeOH : H2O (5 : 1) and finally dried in vacuum
to afford the complexes.15
2.4. Experimental animals
Artemia salina Leach (brine shrimp eggs) collected from pet
shops was kept properly under controlled temperature and was
used as the test organism.16 Ten (n = 10) living shrimps were added
to each of the test tubes containing 5 ml of simulated sea water.
2.5. Antimicrobial activity
Tolfenamic acid and its complexes were tested for antimicrobial
activities by the standardized disk diffusion method.17,18 In vitro
antimicrobial screening was done against numerous strains of bac-
teria and fungi. The obtained results were compared with standard
antibiotic, ciprofloxacin.2.6. Cytotoxic activity
Cytotoxicity was evaluated by using brine shrimp lethality test
according to the reported method.19,20 In this test, dimethyl sulfox-
ide and vincristine sulfate were used as negative control and pos-
itive control, respectively. Ten matured shrimps were applied to
each of all test tubes of tolfenamic acid and its complexes. After
24 hours, the morbidity of brine shrimps was observed. An approx-
imate linear correlation was observed by plotting logarithm of con-
centration versus percentage of mortality.
2.7. Antioxidant activity
The antioxidant activity of tolfenamic acid and its complexes
was assessed by 1,1-dipheny-l-2-picryldrazyl and estimated by
reported methods.21–23 Here, butylated hydroxyl toluene was used
as standards and DPPH solution was used as control.24 The absor-
bance was measured by UV spectrophotometer at a wave length of
570 nm.
Inhibition of free radical was estimated by following equation:
Inhibition of free radical % ¼ ðAc  AsÞ=Ac  100 where;
Ac = Absorbance of the control and As = Absorbance of the tolfe-
namic acid and its complexes. The 50% inhibitory concentration
IC50 was calculated by plotting the inhibition concentration versus
standard tolfenamic acid complex concentration.
2.8. Statistical analysis
Statistical analyses were done by using the Statistical Package
for Social Science (SPSS) version 16.0 software, and statistical dif-
ferences between groups were analyzed by one-way analysis of
variance ANOVA followed by Dunnett’s t-tests.16 Data’s were pre-
sented as means ± SEM of three parallel measurements and differ-
ences were considered significant at p < 0.05.
3. Results and discussion
3.1. Characterization of metal complexes
Characterization of the complexes of tolfenamic acid was done
by analyzing FTIR spectra, UV–vis Spectra, and DSC
thermograms.15
3.2. Antimicrobial activity
To determine antimicrobial activity of metal complexes of tolfe-
namic acid, they were tested against some gram positive and some
gram negative bacteria and some fungi.25 Here, five gram positive
bacteria namely, B. cereus, B. megaterium, B. subtilis, S. lutea, and
Staph. aureus as well as eight gram negative bacteria namely,
E. coli, P. aeruginosa, S. paratyphi, S. typhi, V. parahemolyticus, S. boy-
dii, S. dysenteriae, and V. mimicus and also three fungi namely, C.
albicans, A. niger, and S. cerevacae were used. In this study, tolfe-
namic acid complexes showed mild to moderate antimicrobial
activity except cobalt complex of tolfenamic acid. The zone of inhi-
bition for tolfenamic acid-copper and tolfenamic acid-zinc were
18–20 mm and 10–12 mm respectively, which was compared to
standard ciprofloxacin with an inhibition zone of 44–46 mm as
mentioned in Table 1.
3.3. Cytotoxic activity
The results obtained from brine shrimp lethality assay are pre-
sented in Table 2. The LC50 denoted the concentration by which
Table 1
Antimicrobial activity of tolfenamic acid and its metal complexes.
Test organism Determination of zone of inhibition (mm)
TOL TOCU TOCO TOZ CIP
Gram positive bacteria
Bacillus cereus – 18 – 10 45
Bacillus megaterium – 18 – 11 45
Bacillus subtilis – 19 – 11 45
Sarcinalutea – 18 – 10 45
Staphylococcus aureus – 19 – 10 45
Gram Negative bacteria
Escherichia coli – 20 – 12 44
Pseudomonas aeruginosa – 18 – 10 45
Salmonella paratyphi – 19 – 11 46
Salmonella typhi – 19 – 12 46
Vibrio parahemolyticus – 19 – 10 44
Shigellaboydii – 18 – 11 45
Shigelladysenteriae – 19 – 10 45
Vibrio mimicus – 18 – 10 45
Fungi
Candida albicans – 18 – 11 45
Aspergillus niger – 19 – 11 45
Sacharomycescerevacae – 18 – 11 45
TOL = Tolfenamic acid, TOCU = Cu complex of Tolfenamic acid, TOCO = Co complex
of Tolfenamic acid, TOZ = Zn complex of Tolfenamic acid, CIP = Ciprofloxacin
(Standard).
Table 2
Cytotoxic activity of tolfenamic acid and its complexes.
Test samples LC50 (lg/ml)
Vincristine sulfate (VS) 0.82 ± 0.09
Tolfenamic acid 1.23 ± 0.91***
Cu complex of tolfenamic acid 1.12 ± 0.12***
Co complex of tolfenamic acid 1.17 ± 0.56***
Zn complex of tolfenamic acid 1.35 ± 0.24**
Data of LC50 represents mean ± SEM of triplicate analysis and significant at
***p < 0.001, **p < 0.01 compared to vincristine sulfate.
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and tolfenamic acid-Co complex exhibited significantly highest
cytotoxicity with the LC50 values of 1.12 ± 0.12 lg/ml,
1.17 ± 0.56 lg/ml respectively, compared to the vincristine sulfate
having LC50 value of 0.82 ± 0.09 lg/ml. Also, tolfenamic acid and
tolfenamic acid-Zn complex exhibited cytotoxicity with the LC50
values of 1.23 ± 0.91 lg/ml, 1.35 ± 0.24 lg/ml, respectively.
3.4. Antioxidant activity
The antioxidant activity of tolfenamic acid and its complexes
are shown in Table 3. Here, tert-butyl-1-hydroxytolune (BHT)
was used as reference standard.27 In this case, parent tolfenamic
acid, tolfenamic acid-Cu complex, tolfenamic acid-Co complex
and tolfenamic acid-Zn complex showed significant free radical
scavenging activity with IC50 value 20.56 ± 0.71 lg/ml,
13.61 ± 0.58 mg/ml, 15.38 ± 0.09 mg/ml and 47.28 ± 0.89 mg/ml,
respectively.Table 3
Antioxidant activity of tolfenamic acid and its complexes.
Sample % of inhibition Free radical scavenging
activity IC50 mg/ml
tert-Butyl-1-hydroxytolune (BHT) 65.74 ± 0.15 11.84 ± 0.65
Tolfenamic acid 31.63 ± 0.47 20.56 ± 0.71
Cu complex of tolfenamic acid 61.18 ± 0.41*** 13.61 ± 0.58***
Co complex of tolfenamic acid 56.59 ± 0.14** 15.38 ± 0.09**
Zn complex of tolfenamic acid 47.28 ± 0.89** 16.21 ± 0.16**
Values are expressed as the mean ± SEM of triplicate analysis and significant at
***p < 0.001, **p < 0.01 compared to standard BHT.4. Conclusion
Pharmacological investigation on metal complexes of tolfe-
namic acid was the main purpose of designing the study. In addi-
tion, search for new pharmacological responses such as
antioxidant, anticancer, and antimicrobial potency was, also, a
key drive to prepare the new compounds; therefore, complexes
of tolfenamic acid, which might exhibit enhanced biological prop-
erties than its parent compound. The Co and Cu complex can be
developed as antitumor drugs having very promising antioxidant
properties. They can also be used for their cytoprotective role in
neurodegenerative diseases. Moreover, the Cu and Co complexes
possess significant cytotoxic potency compared to vincristine,
which may lead to the development of new anticancer drugs; how-
ever, further researches are needed to test the compound against
other anticancer agents. Emergence of Cu and Zn complexes of
tolfenamic acid as future antimicrobial agents can be predicted
and bioactivity guided studies can be further performed with a
view to developing new classes of antimicrobial agents.
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